Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Deerfield Discovers Gender Affects Treatment and Outcome in Abdominal Aortic Aneurysm

New York, NY – December 21, 2017 – Deerfield announced today the publication of “Persisting disparities between sexes in outcomes of ruptured abdominal aortic aneurysm hospitalizations” in the journal Scientific Reports. Scientific Reports is a peer-reviewed, open-access journal from Nature Research. This is one of 12 articles written by Deerfield this year that has been published in peer reviewed journals.

The article, written by Deerfield Institute’s Mark Stuntz, Céline Audibert and Zheng Su, examines the discrepancies between the sexes in outcomes of ruptured abdominal aortic aneurysms (rAAA). Deerfield showed that although the incidence and mortality for rAAA has generally improved over time for both males and females, discrepancies still exist between the male and female population. Its findings revealed that females remain at a higher risk of in-hospital death than males and are less likely to undergo rAAA repair. In fact, even if females did receive surgery, they were more likely to have fatal outcomes. This article is intended to stimulate further exploration of gender based differences in the treatment of abdominal aortic aneurysms with the goal of improving outcomes.

About Deerfield

Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy.

For more information, please visit www.deerfield.com.

Contacts

Deerfield Management Company
Karen Heidelberger, 212-551-1600
[email protected] 

The article can be found at http://www.nature.com/articles/s41598-017-18451-2